Clinical Investigator
Taisho Director Taisho Director
Taisho Pharmaceutical Co., Ltd.
Total Trials
3
As PI
0
Completed
1
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
DRUG(3)
TS-172
2 trials
phase_1
taisho-pharmaceutical-co-ltdTS-172 20~60 mg/day
1 trial
phase_3
taisho-pharmaceutical-co-ltd2 unique interventions1 categories
Analytics
Trial Phases
Phase 12
Phase 31
Trial Status
Completed1
Recruiting2
Role Distribution
Other Roles3
Activity Timeline
Clinical Trials (3)
A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders
Hyperphosphatemia Patients on Hemodialysis
StudydirectorStart date: 2026-01-09
A Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment
Patients With Mild or Moderate Hepatic Impairment
StudydirectorStart date: 2025-12-23
A Pharmacodynamic Study of TS-172 in Healthy Adult Male Subjects
Healthy Adult Male Subjects
StudydirectorStart date: 2025-08-05
Research Network
Collaboration Network
1 collaborators·0 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Taisho Pharmaceutical Co., Ltd.
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
1 similar investigators found
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders
Hyperphosphatemia Patients on Hemodialysis
A Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment
Patients With Mild or Moderate Hepatic Impairment
A Pharmacodynamic Study of TS-172 in Healthy Adult Male Subjects
Healthy Adult Male Subjects
All 3 trials loaded